We are a Biomanufacturing company addressing the key bottleneck limiting AI’s impact in biotech: the broken Design–Build–Test–Learn loop. While AI can create novel proteins in hours, conventional bioreactors still require years and tens of millions of dollars to scale production. This gap increasingly restricts real-world deployment. We have engineered a metabolically efficient organism into a living bioreactor capable of producing proteins, enzymes, and biologics at a fraction of traditional costs, scaling from lab to industrial production in months. Led by pioneers in gene editing and experienced biotech builders, our platform enables faster, more flexible manufa